NNVC logo

NanoViricides (NNVC) Current Liabilities

Annual Current Liabilities

$1.36 M
+$824.50 K+154.31%

June 30, 2024


Summary


Performance

NNVC Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNNVCbalance sheetmetrics:

Quarterly Current Liabilities

$1.63 M
+$273.90 K+20.16%

September 1, 2024


Summary


Performance

NNVC Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNNVCbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

NNVC Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+154.3%+100.8%
3 y3 years+287.0%+205.6%
5 y5 years-52.3%+205.6%

NNVC Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+287.0%at high+374.2%
5 y5-year-52.3%+287.0%-58.1%+381.2%
alltimeall time-79.8%+1958.8%-76.5%+392.4%

NanoViricides Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$1.63 M(+20.2%)
Jun 2024
$1.36 M(+154.3%)
$1.36 M(+67.1%)
Mar 2024
-
$813.30 K(-14.5%)
Dec 2023
-
$951.10 K(+0.3%)
Sep 2023
-
$948.30 K(+77.5%)
Jun 2023
$534.30 K(+29.4%)
$534.30 K(+53.2%)
Mar 2023
-
$348.70 K(-24.9%)
Dec 2022
-
$464.60 K(-10.4%)
Sep 2022
-
$518.40 K(+25.6%)
Jun 2022
$412.80 K(+17.6%)
$412.80 K(+6.7%)
Mar 2022
-
$386.70 K(+12.3%)
Dec 2021
-
$344.30 K(-60.4%)
Sep 2021
-
$869.50 K(+147.7%)
Jun 2021
$351.10 K(-83.7%)
$351.10 K(-59.7%)
Mar 2021
-
$871.30 K(+156.8%)
Dec 2020
-
$339.30 K(-81.8%)
Sep 2020
-
$1.87 M(-13.5%)
Jun 2020
$2.16 M(-24.3%)
$2.16 M(-2.6%)
Mar 2020
-
$2.21 M(-43.2%)
Dec 2019
-
$3.90 M(+46.7%)
Sep 2019
-
$2.66 M(-6.7%)
Jun 2019
$2.85 M(+223.0%)
$2.85 M(+162.7%)
Mar 2019
-
$1.08 M(-6.8%)
Dec 2018
-
$1.16 M(-16.4%)
Sep 2018
-
$1.39 M(+57.9%)
Jun 2018
$881.90 K(-81.1%)
$881.90 K(-72.4%)
Mar 2018
-
$3.19 M(-52.6%)
Dec 2017
-
$6.74 M(+27.5%)
Sep 2017
-
$5.28 M(+13.3%)
Jun 2017
$4.67 M(-30.8%)
$4.67 M(+1307.0%)
Mar 2017
-
$331.60 K(-94.7%)
Dec 2016
-
$6.32 M(-9.0%)
Sep 2016
-
$6.94 M(+2.9%)
Jun 2016
$6.74 M(+1022.3%)
$6.74 M(+1.9%)
Mar 2016
-
$6.62 M(+351.3%)
Dec 2015
-
$1.47 M(+49.2%)
Sep 2015
-
$983.10 K(+63.6%)
DateAnnualQuarterly
Jun 2015
$600.90 K(+16.1%)
$600.90 K(+14.8%)
Mar 2015
-
$523.40 K(-53.3%)
Dec 2014
-
$1.12 M(+49.0%)
Sep 2014
-
$752.90 K(+45.4%)
Jun 2014
$517.70 K(-56.1%)
$517.70 K(-57.1%)
Mar 2014
-
$1.21 M(-10.9%)
Dec 2013
-
$1.36 M(-27.4%)
Sep 2013
-
$1.87 M(+58.5%)
Jun 2013
$1.18 M(-33.8%)
$1.18 M(-73.3%)
Mar 2013
-
$4.41 M(+215.9%)
Dec 2012
-
$1.40 M(-10.3%)
Sep 2012
-
$1.56 M(-12.5%)
Jun 2012
$1.78 M(+203.1%)
$1.78 M(+121.3%)
Mar 2012
-
$804.10 K(-31.4%)
Dec 2011
-
$1.17 M(+18.3%)
Sep 2011
-
$991.20 K(+68.8%)
Jun 2011
$587.20 K(-76.3%)
$587.20 K(-27.5%)
Mar 2011
-
$809.70 K(-54.7%)
Dec 2010
-
$1.79 M(+2.5%)
Sep 2010
-
$1.75 M(-29.4%)
Jun 2010
$2.47 M(+379.7%)
$2.47 M(+158.0%)
Mar 2010
-
$958.70 K(-24.0%)
Dec 2009
-
$1.26 M(+126.4%)
Sep 2009
-
$557.10 K(+8.0%)
Jun 2009
$515.70 K(-49.7%)
$515.70 K(-23.7%)
Mar 2009
-
$675.70 K(+21.0%)
Dec 2008
-
$558.60 K(-44.2%)
Sep 2008
-
$1.00 M(-2.2%)
Jun 2008
$1.02 M(+20.5%)
$1.02 M(+99.6%)
Mar 2008
-
$513.20 K(+33.1%)
Dec 2007
-
$385.60 K(-49.3%)
Sep 2007
-
$760.90 K(-10.5%)
Jun 2007
$849.90 K(+48.0%)
$849.90 K(+9.9%)
Mar 2007
-
$773.40 K(+11.6%)
Dec 2006
-
$693.20 K(+45.9%)
Sep 2006
-
$475.20 K(-17.2%)
Jun 2006
$574.10 K(+769.8%)
$574.10 K
Jun 2005
$66.00 K
-

FAQ

  • What is NanoViricides annual total current liabilities?
  • What is the all time high annual current liabilities for NanoViricides?
  • What is NanoViricides annual current liabilities year-on-year change?
  • What is NanoViricides quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for NanoViricides?
  • What is NanoViricides quarterly current liabilities year-on-year change?

What is NanoViricides annual total current liabilities?

The current annual current liabilities of NNVC is $1.36 M

What is the all time high annual current liabilities for NanoViricides?

NanoViricides all-time high annual total current liabilities is $6.74 M

What is NanoViricides annual current liabilities year-on-year change?

Over the past year, NNVC annual total current liabilities has changed by +$824.50 K (+154.31%)

What is NanoViricides quarterly total current liabilities?

The current quarterly current liabilities of NNVC is $1.63 M

What is the all time high quarterly current liabilities for NanoViricides?

NanoViricides all-time high quarterly total current liabilities is $6.94 M

What is NanoViricides quarterly current liabilities year-on-year change?

Over the past year, NNVC quarterly total current liabilities has changed by +$819.40 K (+100.75%)